Interaction of Microbiome, Diet, and Hospitalizations Between Brazilian and American Patients With Cirrhosis

Imagem de Miniatura
Arquivos
art_ALVARES-DA-SILVA_Interaction_of_Microbiome_Diet_and_Hospitalizations_Between_Brazilian_2022.PDF (1.46 MB)
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
ALVARES-DA-SILVA, Mario R.
FAGAN, Andrew
LONGO, Larisse
THOEN, Rutiane U.
FERREIRA, Renee M. Tanaka
MCGEORGE, Sara
SHAMSADDINI, Amirhossein
Citação
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, v.20, n.4, p.930-940, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND & AIMS: Gut microbiota are affected by diet, country, and affect outcomes in cirrhosis. Western diets are associated with dysbiosis. Comparisons with other diets is needed. We aimed to compare cirrhosis patients from the United States with cirrhosis patients from Brazil with respect to diet, microbiota, and impact on hospitalizations. METHODS: Healthy controls and compensated/decompensated outpatients with cirrhosis from the United States and Brazil underwent dietary recall and stool for 16S ribosomal RNA sequencing. Demographics and medications/cirrhosis details were compared within and between countries. Patients with cirrhosis were followed up for 90-day hospitalizations. Regression for Shannon diversity was performed within cirrhosis. Regression for hospitalizations adjusting for clinical and microbial variables was performed. RESULTS: Model for end-stage liver disease (MELD), diabetes, ascites, and albumin were similar, but more Americans were men, had higher hepatic encephalopathy and alcohol/hepatitis C etiology, with lower nonalcoholic fatty liver disease than Brazilians. Brazilians had higher cereal, rice, and yogurt intake vs the United States. As disease progressed, cereals, rice/beans, coffee, and chocolate consumption was reduced. Microbial diversity was higher in Brazilians. Within cirrhosis, high diversity was related to Brazilian origin (P < .0001), age, and cereal intake (P = .05), while high MELD scores (P = .009) and ascites (P = .05) did the reverse. Regardless of stage, beneficial taxa and taxa associated with grant and yogurt intake were higher (Ruminococcaceae, Christensenellacae, and Prevotellaceae), while pathobionts (Porphyromonadaceae, Sutterellaceae, and Enterobacteriaceae) were lower in Brazilians. More Americans were hospitalized vs Brazilians (P = .002). On regression, MELD (P = .001) and ascites (P = .001) were associated with higher hospitalizations, while chocolate (P = .03) and Brazilian origin (P = .001) were associated with lower hospitalizations with/without microbiota inclusion. CONCLUSIONS: Brazilian cirrhotic patients follow a diet richer in cereals and yogurt, which is associated with higher microbial diversity and beneficial microbiota and could contribute toward lower hospitalizations compared with a Western-diet-consuming American cohort.
Palavras-chave
Western Diet, Chocolate, Cereals, Microbial Diversity, Yogurt
URI
https://observatorio.fm.usp.br/handle/OPI/51499
Referências
  1. Acharya C, 2021, GASTROENTEROLOGY, V160, P556, DOI 10.1053/j.gastro.2020.10.056
  2. Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014
  3. Bajaj JS, 2020, LIVER INT, V40, P1395, DOI 10.1111/liv.14437
  4. Bajaj JS, 2018, HEPATOLOGY, V68, P234, DOI 10.1002/hep.29791
  5. Bajaj JS, 2015, HEPATOLOGY, V62, P1260, DOI 10.1002/hep.27819
  6. Bajaj JS, 2014, J HEPATOL, V60, P940, DOI 10.1016/j.jhep.2013.12.019
  7. BIANCHI GP, 1993, J INTERN MED, V233, P385, DOI 10.1111/j.1365-2796.1993.tb00689.x
  8. Chen YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep34055
  9. Cox IJ, 2020, LIVER INT, V40, P416, DOI 10.1111/liv.14256
  10. De Gottardi A, 2012, AM J CLIN NUTR, V96, P584, DOI 10.3945/ajcn.112.040469
  11. Dias DM, 2019, FOOD RES INT, V123, P172, DOI 10.1016/j.foodres.2019.04.060
  12. Dubinkina VB, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0359-2
  13. European Assoc Study Liver, 2019, J HEPATOL, V70, P172, DOI 10.1016/j.jhep.2018.06.024
  14. Gonzalez S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051287
  15. Hernaez R, 2022, CLIN GASTROENTEROL H, V20, P194, DOI 10.1016/j.cgh.2020.08.045
  16. huttenhower, MAASLIN
  17. Jabbar KS, 2021, GUT, V70, P1117, DOI 10.1136/gutjnl-2020-321466
  18. Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
  19. Lapidot Y, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00153-20
  20. Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976
  21. Liu HY, 2021, FOOD SCI NUTR, V9, P217, DOI 10.1002/fsn3.1986
  22. Nader LA, 2014, LIVER INT, V34, P844, DOI 10.1111/liv.12470
  23. Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100
  24. Pascale A, 2018, ENDOCRINE, V61, P357, DOI 10.1007/s12020-018-1605-5
  25. portaldab, DIETARY GUIDELINES B
  26. qiime, 454 OVERVIEW TUTORIA
  27. Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568
  28. Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
  29. Sanchez-Tapia M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041182
  30. Sandhu KV, 2017, TRANSL RES, V179, P223, DOI 10.1016/j.trsl.2016.10.002
  31. Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
  32. Sikaroodi M, 2012, BIOTECHNIQUES, V53, P381, DOI 10.2144/000113967
  33. Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165
  34. Sung CM, 2019, CELL MOL GASTROENTER, V8, P301, DOI 10.1016/j.jcmgh.2019.04.008
  35. Trebicka J, 2021, NAT REV GASTRO HEPAT, V18, P167, DOI 10.1038/s41575-020-00376-3
  36. Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
  37. Whitfield JB, 2021, AM J GASTROENTEROL, V116, P106, DOI 10.14309/ajg.0000000000000833

Coleções
Artigos e Materiais de Revistas Científicas - FM/MGT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/07
Artigos e Materiais de Revistas Científicas - ODS/03